NCT03853889

Brief Summary

Depending on the physiology of pregnancy, the risk of increased aspiration, difficult airway, increased oxygen consumption and reduced functional residual capacity, breathing problems make general anesthesia application risky. In obstetric operations, neuraxial anesthesia is preferred because of both maternal and maternal mortality and morbidity. Epidural area has decreased due to pregnancy physiology. Previous studies have shown that the blood given to the epidural area increases the intracranial pressure by compressing the dura mater.Optic nerve diameter measurements ultrasound guided is a non-invasive and reliable method for detecting intracranial pressure increase. In this study, aimed to compare the optic nerve sheath diameter before and after epidural anesthesia with USG.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 26, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

June 28, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2019

Completed
Last Updated

July 5, 2019

Status Verified

July 1, 2019

Enrollment Period

2 months

First QC Date

January 11, 2019

Last Update Submit

July 2, 2019

Conditions

Keywords

optic nerve sheath pressurenoninvasive intracranial pressure measurementepidural anesthesiacesarean

Outcome Measures

Primary Outcomes (1)

  • increase in the diameter of the optic nerve sheath after epidural anesthesia

    increase of intracranial pressure as a result of the administration of 20 ml of local anesthetic to the epidural area and its reflection on the diameter of the optic nerve sheath

    Basal(T0),Immediately after administration of epidural anesthesia(T1), after epidural anesthesia 15 min(T2), 30 min (T3),60 min (T4)

Study Arms (2)

preepidural ONSD

ACTIVE COMPARATOR

The diameter of the optic nerve sheath to be measured(ONSD) with the help of ultrasonography before epidural anesthesia(pre epidural ONSD). The measurement will be measured 3 mm behind the optical disc. The measurements shall be applied in both transverse and sagittal planes for both eyes and the arithmetic mean of the four measured values.

Procedure: USG guided ONSD measurement preepidural

post epidural ONSD

EXPERIMENTAL

The diameter of the optic nerve sheath to be measured with the help of ultrasonography Immediately after epidural anesthesia(post epidural ONSD) (T1), 15 minutes (T2), 30 min (T3), 60. min (T4) epidural anesthesia. The measurement will be measured 3 mm behind the optical disc. The measurements shall be applied in both transverse and sagittal planes for both eyes and the arithmetic mean of the four measured values.

Procedure: USG guided ONSD measurement preepidural

Interventions

Measurement of the diameter of the optic nerve sheath preepidural and postepidural anesthesia

Also known as: USG guided ONSD measurement postepidural
post epidural ONSDpreepidural ONSD

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • epidural anesthesia patients
  • years patients
  • American Society of Anesthesiologists status I-II patients

You may not qualify if:

  • Patients with allergy to any of the drugs to be used in the study,
  • patients with severe heart failure,
  • atrial and ventricular arrhythmias,
  • severe valve disease,
  • electrolyte disorder,
  • renal failure, preeclampsia, eclampsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • murat bilgi, MD

    Bolu Abant İzzet Baysal University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

murat bilgi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 11, 2019

First Posted

February 26, 2019

Study Start

June 28, 2019

Primary Completion

August 17, 2019

Study Completion

December 17, 2019

Last Updated

July 5, 2019

Record last verified: 2019-07